Cargando…
CYP17A1 deficient XY mice display susceptibility to atherosclerosis, altered lipidomic profile and atypical sex development
CYP17A1 is a cytochrome P450 enzyme with 17-alpha-hydroxylase and C17,20-lyase activities. CYP17A1 genetic variants are associated with coronary artery disease, myocardial infarction and visceral and subcutaneous fat distribution; however, the underlying pathological mechanisms remain unknown. We ai...
Autores principales: | Aherrahrou, Redouane, Kulle, Alexandra E., Alenina, Natalia, Werner, Ralf, Vens-Cappell, Simeon, Bader, Michael, Schunkert, Heribert, Erdmann, Jeanette, Aherrahrou, Zouhair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260244/ https://www.ncbi.nlm.nih.gov/pubmed/32472014 http://dx.doi.org/10.1038/s41598-020-65601-0 |
Ejemplares similares
-
Identification of a novel ovine LH-beta promoter region, which dramatically enhances its promoter activity
por: Aherrahrou, Redouane, et al.
Publicado: (2015) -
Effect of Differences in the Microbiome of Cyp17a1-Deficient Mice on Atherosclerotic Background
por: Künstner, Axel, et al.
Publicado: (2021) -
Etidronate prevents dystrophic cardiac calcification by inhibiting macrophage aggregation
por: Bauer, Carolin, et al.
Publicado: (2018) -
Dare to Compare. Development of Atherosclerotic Lesions in Human, Mouse, and Zebrafish
por: Vedder, Viviana L., et al.
Publicado: (2020) -
Induced Pluripotent Stem Cells (iPSCs) in Vascular Research: from Two- to Three-Dimensional Organoids
por: Trillhaase, Anja, et al.
Publicado: (2021)